AI주식인사이트AI Stock Insight
C

애드바이오텍

179530KOSDAQ의약품 제조업

43.3 / 100

Reference Date: 2026-07-24

Financial Score9.0 / 40
News Sentiment21.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 9.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

AdvaTek is a biotech company developing eco-friendly products for livestock, aquaculture, and human use through technologies like IgY immune yolk antibodies, VHH nanobody antibodies, and microbial agents. Its IgY technology offers high titer and thermal stability, while VHH nanobodies provide strong tissue penetration and easy mass production, positioning them as promising alternatives to antibiotics and vaccines.

Number of Employees

64people

Average Salary

42.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 11.234.0Point
PBR
3.46Industry Average 0.810.0Point

4.3x industry avg (risky)

ROE
-40.31Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
25.03Industry Average 12.430.0Point

2.0x industry avg (risky)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲11.1% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲14.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -70.2% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 1,738Won52-week high 4,17052-week low 1,350
1-month return1.0Point

1m -9.43% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0
  • Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-07-21
  • Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-07-21
  • Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-07-21
  • Neutral합병등종료보고서(자산양수도)2026-07-03
  • Neutral[기재정정]주요사항보고서(자기전환사채매도결정)2026-07-03